Hein J Boot
Overview
Explore the profile of Hein J Boot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
King A, Sonsma J, Vriend H, van der Sande M, Feltkamp M, Boot H, et al.
PLoS One
. 2016 Apr;
11(4):e0154977.
PMID: 27123932
[This corrects the article DOI: 10.1371/journal.pone.0152782.].
2.
King A, Sonsma J, Vriend H, van der Sande M, Feltkamp M, Boot H, et al.
PLoS One
. 2016 Apr;
11(4):e0152782.
PMID: 27070907
Objectives: Intratypic molecular variants of human papillomavirus (HPV) type-16 and -18 exist. In the Netherlands, a bivalent vaccine, composed of recombinant L1 proteins from HPV-16 and -18, is used to...
3.
Mooij S, Boot H, Speksnijder A, Meijer C, King A, Verhagen D, et al.
PLoS One
. 2014 Jun;
9(6):e98955.
PMID: 24896848
Objectives: Our aim was to assess incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men (MSM). Methods: MSM aged ≥18 years were...
4.
Mooij S, Boot H, Speksnijder A, Stolte I, Meijer C, Snijders P, et al.
AIDS
. 2014 Jan;
27(13):2117-28.
PMID: 24384590
Objective: Oral infection with human papillomavirus (HPV) is associated with a subset of head and neck cancers. We compared prevalence of, and risk factors for, oral HPV infection among HIV-negative...
5.
Vriend H, Bogaards J, van der Klis F, Scherpenisse M, Boot H, King A, et al.
PLoS One
. 2013 May;
8(4):e60696.
PMID: 23637760
Background: To monitor the impact of human papillomavirus types 16 and 18 vaccine on HPV infection dynamics in the Netherlands, we started an ongoing study in sexually transmitted infection (STI)...
6.
Scherpenisse M, Mollers M, Schepp R, Boot H, Meijer C, Berbers G, et al.
PLoS One
. 2012 Nov;
7(11):e48807.
PMID: 23152809
Objective: This study evaluates trends in antibody seroprevalences of seven high-risk human papillomavirus (hr-HPV) serotypes (HPV16, 18, 31, 33, 45, 52, and 58) between the 1995-96 and 2006-07 sero-surveys among...
7.
Scherpenisse M, Mollers M, Schepp R, Boot H, de Melker H, Meijer C, et al.
Vaccine
. 2012 Sep;
30(47):6686-93.
PMID: 22959981
Background: To obtain insight into the age-specific seroprevalence for seven high-risk human papillomavirus (hr-HPV) serotypes (HPV16, 18, 31, 33, 45, 52, and 58) among the general population in the pre-vaccination...
8.
Molenaar-de Backer M, Lukashov V, van Binnendijk R, Boot H, Zaaijer H
PLoS One
. 2012 Aug;
7(8):e43206.
PMID: 22912828
Parvovirus B19 (B19V) can cause infection in humans. To date, three genotypes of B19V, with subtypes, are known, of which genotype 1a is the most prevalent genotype in the Western...
9.
Vriend H, Op de Coul E, van de Laar T, Urbanus A, van der Klis F, Boot H
Eur J Public Health
. 2012 Mar;
22(6):819-21.
PMID: 22461704
A population-based anti-hepatitis C virus (HCV) prevalence is important for surveillance purposes and it provides an insight into the burden of disease. In The Netherlands, a recent HCV seroprevalence estimate...
10.
Snijders B, van Lier A, van de Kassteele J, Fanoy E, Ruijs W, Hulshof F, et al.
Vaccine
. 2012 Mar;
30(19):2999-3002.
PMID: 22381073
To estimate the mumps vaccine effectiveness (VE) during a large genotype D mumps outbreak, we conducted a cross-sectional study in eight primary schools and associated households in the Netherlands. Questionnaires...